VAERS Explorer
Back to explore

Report #2824997

Received Feb 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
AR
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Erythema

Symptom narrative

breakout of red dots around her mouth/ looking like fever blisters before they blistered; This non-serious case was reported by a consumer via call center representative and described the occurrence of red spotty rash in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced red spotty rash (Verbatim: breakout of red dots around her mouth/ looking like fever blisters before they blistered). The outcome of the red spotty rash was unknown. It was unknown if the reporter considered the red spotty rash to be related to Shingrix. It was unknown if the company considered the red spotty rash to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JAN-2025 Reporter was the patient who received her first dose of Shingrix a little over a week ago (from the date of reporting). She stated that the day after the vaccination, she experienced a breakout of red dots around her mouth. She described it as looking like fever blisters before they blistered.